Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis

Background: Proton pump inhibitors (PPI) are generally considered to be one of the well-established prescription drug classes and are commonly used to treat most acid-related diseases. However, a growing body of literature showing an association between gastric and colorectal cancer risk and PPI use...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Huizhu, Zhang, Ruiqiu, Zhang, Pei, Chen, Zhaoyang, Hua, Yuqing, Huang, Xin, Li, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060974/
https://www.ncbi.nlm.nih.gov/pubmed/37007006
http://dx.doi.org/10.3389/fphar.2023.1129948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060974/
https://www.ncbi.nlm.nih.gov/pubmed/37007006
http://dx.doi.org/10.3389/fphar.2023.1129948

Ejemplares similares